278 related articles for article (PubMed ID: 33034797)
1. Long non-coding RNAs as targets for immunosuppressive drug teriflunomide in anti-cancer potential for hepatocellular carcinoma.
Xu Y; Shen D; Liu J; Xu X; Tu J; Qin L; Jiang L; Qian H; Guo F
J Mol Histol; 2020 Dec; 51(6):659-673. PubMed ID: 33034797
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive analysis of long non‑coding RNA‑messenger RNA‑microRNA co‑expression network identifies cell cycle‑related lncRNA in hepatocellular carcinoma.
Zhu HR; Yu XN; Zhang GC; Shi X; Bilegsaikhan E; Guo HY; Liu LL; Cai Y; Song GQ; Liu TT; Dong L; Janssen HLA; Weng SQ; Wu J; Shen XZ; Zhu JM
Int J Mol Med; 2019 Nov; 44(5):1844-1854. PubMed ID: 31485608
[TBL] [Abstract][Full Text] [Related]
3. The long noncoding RNA expression profile of hepatocellular carcinoma identified by microarray analysis.
Zhu J; Liu S; Ye F; Shen Y; Tie Y; Zhu J; Jin Y; Zheng X; Wu Y; Fu H
PLoS One; 2014; 9(7):e101707. PubMed ID: 25025236
[TBL] [Abstract][Full Text] [Related]
4. Identification of long noncoding RNA expression profile in oxaliplatin-resistant hepatocellular carcinoma cells.
Yin X; Zheng SS; Zhang L; Xie XY; Wang Y; Zhang BH; Wu W; Qiu S; Ren ZG
Gene; 2017 Jan; 596():53-88. PubMed ID: 27729273
[TBL] [Abstract][Full Text] [Related]
5. Integrated analysis of long noncoding RNA expression profiles in lymph node metastasis of hepatocellular carcinoma.
Ma J; Zhang L; Yang P; Zeng ZC; Xiang ZL
Gene; 2018 Nov; 676():47-55. PubMed ID: 29981417
[TBL] [Abstract][Full Text] [Related]
6. Long noncoding RNAs in hepatitis B virus-related hepatocellular carcinoma.
Yu TT; Xu XM; Hu Y; Deng JJ; Ge W; Han NN; Zhang MX
World J Gastroenterol; 2015 Jun; 21(23):7208-17. PubMed ID: 26109807
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNAs are differentially expressed in hepatocellular carcinoma cell lines with differing metastatic potential.
Fang TT; Sun XJ; Chen J; Zhao Y; Sun RX; Ren N; Liu BB
Asian Pac J Cancer Prev; 2014; 15(23):10513-24. PubMed ID: 25556502
[TBL] [Abstract][Full Text] [Related]
8. Invasion and metastasis-related long noncoding RNA expression profiles in hepatocellular carcinoma.
Gao Y; Chen G; Zeng Y; Zeng J; Lin M; Liu X; Liu J
Tumour Biol; 2015 Sep; 36(10):7409-22. PubMed ID: 25900874
[TBL] [Abstract][Full Text] [Related]
9. RNA sequencing reveals the long noncoding RNA and mRNA profiles and identifies long non-coding RNA TSPAN12 as a potential microvascular invasion-related biomarker in hepatocellular carcinoma.
Lu J; Li B; Xiong X; Cheng N
Biomed Pharmacother; 2020 Jun; 126():110111. PubMed ID: 32222644
[TBL] [Abstract][Full Text] [Related]
10. Expression profile of altered long non-coding RNAs in patients with HBV-associated hepatocellular carcinoma.
Pan YF; Qin T; Feng L; Yu ZJ
J Huazhong Univ Sci Technolog Med Sci; 2013 Feb; 33(1):96-101. PubMed ID: 23392715
[TBL] [Abstract][Full Text] [Related]
11. Microarray analysis on the lncRNA expression profile in male hepatocelluar carcinoma patients with chronic hepatitis B virus infection.
Niu J; Lin Y; Liu P; Yu Y; Su C; Wang X
Oncotarget; 2016 Nov; 7(46):76169-76180. PubMed ID: 27769059
[TBL] [Abstract][Full Text] [Related]
12. Differentially Expressed Long Noncoding RNAs Involved in FUBP1 Promoting Hepatocellular Carcinoma Cells Proliferation.
Li X; Yu H; Xu F; Wu Y; Sheng J
Biomed Res Int; 2021; 2021():6664519. PubMed ID: 33954195
[TBL] [Abstract][Full Text] [Related]
13. Overlapping and unique roles played by ROCK1 and 2 in the modulation of coding and long noncoding RNA expression.
Zhou HM; Zhang JG; Zhang X; Fan GR; Liu GL; Li Q
BMC Genomics; 2019 May; 20(1):409. PubMed ID: 31117934
[TBL] [Abstract][Full Text] [Related]
14. The mRNA, miRNA and lncRNA networks in hepatocellular carcinoma: An integrative transcriptomic analysis from Gene Expression Omnibus.
Xu JH; Chang WH; Fu HW; Yuan T; Chen P
Mol Med Rep; 2018 May; 17(5):6472-6482. PubMed ID: 29512731
[TBL] [Abstract][Full Text] [Related]
15. Bioinformatics analysis of the interactions among lncRNA, miRNA and mRNA expression, genetic mutations and epigenetic modifications in hepatocellular carcinoma.
Lin C; Yuan G; Hu Z; Zeng Y; Qiu X; Yu H; He S
Mol Med Rep; 2019 Feb; 19(2):1356-1364. PubMed ID: 30535497
[TBL] [Abstract][Full Text] [Related]
16. Anti-inflammatory drug, leflunomide and its metabolite teriflunomide inhibit NSCLC proliferation in vivo and in vitro.
Jiang L; Zhang W; Li W; Ling C; Jiang M
Toxicol Lett; 2018 Jan; 282():154-165. PubMed ID: 29050931
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA LINC01503 promotes the progression of hepatocellular carcinoma via activating MAPK/ERK pathway.
Wang MR; Fang D; Di MP; Guan JL; Wang G; Liu L; Sheng JQ; Tian DA; Li PY
Int J Med Sci; 2020; 17(9):1224-1234. PubMed ID: 32547318
[No Abstract] [Full Text] [Related]
18. Teriflunomide, an immunomodulatory drug, exerts anticancer activity in triple negative breast cancer cells.
Huang O; Zhang W; Zhi Q; Xue X; Liu H; Shen D; Geng M; Xie Z; Jiang M
Exp Biol Med (Maywood); 2015 Apr; 240(4):426-37. PubMed ID: 25304315
[TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNA expression profiles in sub-lethal heat-treated hepatoma carcinoma cells.
Deng Q; Chen S; Fu C; Jiang J; Zou M; Tan Y; Wang X; Xia F; Feng K; Ma K; Bie P
World J Surg Oncol; 2017 Jul; 15(1):136. PubMed ID: 28732507
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA URHC regulates cell proliferation and apoptosis via ZAK through the ERK/MAPK signaling pathway in hepatocellular carcinoma.
Xu WH; Zhang JB; Dang Z; Li X; Zhou T; Liu J; Wang DS; Song WJ; Dou KF
Int J Biol Sci; 2014; 10(7):664-76. PubMed ID: 25013376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
